With a growing number of Chinese patients accessing Western medicine for free through clinical trials, some Chinese officials fear that smaller drug companies will attempt to cut corners and conduct riskier trials for new drugs in China. The relatively new Chinese regulatory agency plans to create rules of ethics for foreign drug companies.

Related Summaries